News
03-06-2019, 03:00 AM
Study of Novartis Access program in Kenya demonstrates it is possible to evaluate major pharmaceutical companies' access programs using robust, 'gold standard' methods.
More... (https://www.news-medical.net/news/20190306/Study-to-generate-evidence-on-impact-of-pharmaceutical-industry-led-medicines-access-program.aspx)
More... (https://www.news-medical.net/news/20190306/Study-to-generate-evidence-on-impact-of-pharmaceutical-industry-led-medicines-access-program.aspx)